Uterine fibroids (UFs, AKA leiomyoma) are the most important benign neoplastic threat to
women's health, with costs up to hundreds of billions of health care dollars worldwide …

Fibroids, the most common tumor in women of reproductive age, impact negatively on
women's health and quality of life, and have significant cost implications for their …

Uterine fibroids (also known as leiomyomas or myomas) are the most common form of
benign uterine tumors. Clinical presentations include abnormal bleeding, pelvic masses …

Uterine fibroids are common in women of reproductive age and can have a significant
impact on quality of life and fertility. Although a number of international …

Oral ulipristal acetate (Esmya®; Fibristal®), a synthetic selective progesterone receptor
modulator, is the first selective progesterone modulator to be approved for the treatment of …

ABSTRACT Introduction: Uterine fibroids (UFs) are the most prevalent benign neoplastic
threat originating from myometria of reproductive age women, with a profound financial load …

Uterine fibroids are the most common benign tumors of the female genital tract. The
management of symptomatic fibroids has traditionally been surgical; however, alternative …

Current treatments for fibroids are mainly surgical and expensive, so alternatives need to be
found. It is, therefore, vital to develop and evaluate alternatives to surgical procedures …

Introduction: To-date, the only cure for symptomatic uterine fibroids (UFs) is surgical
intervention. However, surgery may eliminate the hope of future pregnancies; moreover, the …

The pain, bleeding, and anemia associated with uterine fibroids debilitate many women. In
addition to limited efficacy, the side effects of the currently used medical therapies prevent …